Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print August 2, 2002, 10.1148/radiol.2243011517
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2243011517v1
225/1/27    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piñol, V.
Right arrow Articles by Navarro, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piñol, V.
Right arrow Articles by Navarro, S.
(Radiology 2002;225:27-34.)
© RSNA, 2002

Vascular and Interventional Radiology

Percutaneous Self-expanding Metal Stents versus Endoscopic Polyethylene Endoprostheses for Treating Malignant Biliary Obstruction: Randomized Clinical Trial1

Virgínia Piñol, MD, Antoni Castells, MD, Josep M. Bordas, MD, M. Isabel Real, MD, Josep Llach, MD, Xavier Montañà, MD, Faust Feu, MD and Salvador Navarro, MD

1 From the Department of Gastroenterology, Institut de Malalties Digestives (V.P., A.C., J.M.B., J.L., F.F., S.N.), and Vascular and Interventional Radiology Unit, Centre de Diagnòstic per la Imatge, (M.I.R., X.M.), Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain. Received September 14, 2001; revision requested November 15; revision received January 10, 2002; accepted February 28. Supported in part by grants from the Ministerio de Ciencia y Tecnoloía (SAF00-0038), Fondo de Investigación Sanitaria (01/0104-02), and the Agència d’Avaluació de Tecnologia i Recerca Mèdiques of the Generalitat de Catalunya (026/16/2000). V.P. is a research fellow from the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Address correspondence to S.N. (e-mail: snavarro@clinic.ub.es).

PURPOSE: To compare percutaneous self-expanding metal stents with conventional endoscopic polyethylene endoprostheses for treatment of malignant biliary obstruction by means of a prospective randomized clinical trial.

MATERIALS AND METHODS: Patients with biliary obstruction due to inoperable primary carcinoma of the pancreas, gallbladder, or bile ducts or regional lymph node metastases were included. Evaluated outcomes included technical and therapeutic success rates, morbidity and 30-day mortality rates, hospital stay length and readmission, biliary reobstruction, and overall survival rates. Data were analyzed according to both the intention-to-treat principle and the treatment actually administered. Univariate (Kaplan-Meier method) and multivariate (Cox model) analyses were performed.

RESULTS: After randomization, 28 patients were assigned to receive a percutaneous self-expanding metal stent and 26 patients to receive a 12-F endoscopic polyethylene prosthesis. The technical success rates of both implantation procedures were similar (percutaneous, 75% [21 of 28 patients]; endoscopic, 58% [15 of 26 patients]; P = .29), whereas therapeutic success was higher in the percutaneous group (71% [20 of 28 patients] vs 42% [11 of 26 patients]; P = .03). However, major complications were more common in the percutaneous group (61% [17 of 28 patients] vs 35% [nine of 26 patients]; P = .09) but did not account for differences in 30-day mortality rates (percutaneous, 36% [10 of 28 patients]; endoscopic, 42% [11 of 26 patients]; P = .83). Overall median survival was significantly higher in the percutaneous group than in the endoscopic group (3.7 vs 2.0 months; P = .02). Cox regression analysis enabled identification of placement of the percutaneous self-expanding metal stent as the only independent predictor of survival (relative risk, 2.19; 95% CI: 1.11, 4.31; P = .02).

CONCLUSION: Placement of a percutaneous self-expanding metal stent is an alternative to placement of an endoscopic polyethylene endoprosthesis in patients with malignant biliary obstruction.

© RSNA, 2002

Index terms: Bile ducts, interventional procedures, 766.1229, 766.1267, 774.1269 • Bile ducts, stenosis or obstruction, 766.1229, 766.1267, 774.1269 • Pancreas, interventional procedures, 774.1229, 774.1267, 774.1269 • Pancreas, therapeutic radiology, 774.1229, 774.1267, 774.1269




This article has been cited by other articles:


Home page
 Clin Med ResHome page
G. Donelli, E. Guaglianone, R. Di Rosa, F. Fiocca, and A. Basoli
Plastic Biliary Stent Occlusion: Factors Involved and Possible Preventive Approaches
Clin. Med. Res., March 1, 2007; 5(1): 53 - 60.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
H.-J. Wagner
With or Against the Bile Flow?
Radiology, October 1, 2002; 225(1): 7 - 9.
[Full Text] [PDF]